Find Elvitegravir manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

FDF

FINISHED DOSAGE FORMULATIONS

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF DossiersDRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Exclusivities

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

133 RELATED EXCIPIENT COMPANIES

209EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 697761-98-1, Gs-9137, Jtk-303, Vitekta, Gs 9137, Elvitegravir (gs-9137)
Molecular Formula
C23H23ClFNO5
Molecular Weight
447.9  g/mol
InChI Key
JUZYLCPPVHEVSV-LJQANCHMSA-N
FDA UNII
4GDQ854U53

Elvitegravir
Elvitegravir is a modified quinolone antibiotic with activity against human immunodeficiency virus 1. Elvitegravir is an inhibitor of viral integrase and retains activity against integrase mutants that are resistant to Raltegravir.
Elvitegravir is a Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor. The mechanism of action of elvitegravir is as a HIV Integrase Inhibitor, and Cytochrome P450 2C9 Inducer.
1 2D Structure

Elvitegravir

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
6-[(3-chloro-2-fluorophenyl)methyl]-1-[(2S)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxoquinoline-3-carboxylic acid
2.1.2 InChI
InChI=1S/C23H23ClFNO5/c1-12(2)19(11-27)26-10-16(23(29)30)22(28)15-8-14(20(31-3)9-18(15)26)7-13-5-4-6-17(24)21(13)25/h4-6,8-10,12,19,27H,7,11H2,1-3H3,(H,29,30)/t19-/m1/s1
2.1.3 InChI Key
JUZYLCPPVHEVSV-LJQANCHMSA-N
2.1.4 Canonical SMILES
CC(C)C(CO)N1C=C(C(=O)C2=C1C=C(C(=C2)CC3=C(C(=CC=C3)Cl)F)OC)C(=O)O
2.1.5 Isomeric SMILES
CC(C)[C@@H](CO)N1C=C(C(=O)C2=C1C=C(C(=C2)CC3=C(C(=CC=C3)Cl)F)OC)C(=O)O
2.2 Other Identifiers
2.2.1 UNII
4GDQ854U53
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Gs 9137

2. Gs-9137

3. Gs9137

4. Jtk 303

5. Jtk-303

6. Jtk303

7. Vitekta

2.3.2 Depositor-Supplied Synonyms

1. 697761-98-1

2. Gs-9137

3. Jtk-303

4. Vitekta

5. Gs 9137

6. Elvitegravir (gs-9137)

7. Evg

8. Unii-4gdq854u53

9. (s)-6-(3-chloro-2-fluorobenzyl)-1-(1-hydroxy-3-methylbutan-2-yl)-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid

10. 6-(3-chloro-2-fluorobenzyl)-1-[1(s)-(hydroxymethyl)-2-methylpropyl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid

11. Chebi:72289

12. 6-[(3-chloro-2-fluorophenyl)methyl]-1-[(2s)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxoquinoline-3-carboxylic Acid

13. Chembl204656

14. 4gdq854u53

15. D06677

16. 6-(3-chloro-2-fluorobenzyl)-1-((2s)-1-hydroxy-3-methylbutan-2-yl)-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid

17. 6-(3-chloro-2-fluorobenzyl)-1-[(2s)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid

18. Jtk 303

19. 3-quinolinecarboxylic Acid, 6-((3-chloro-2-fluorophenyl)methyl)-1,4-dihydro-1-((1s)-1-(hydroxymethyl)-2-methylpropyl)-7-methoxy-4-oxo-

20. 6-(3-chloro-2-fluorobenzyl)-1-[(1s)-1-(hydroxymethyl)-2-methylpropyl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid

21. Jtk303

22. Elvitegravir [usan]

23. Gs9137

24. Elvitegravir [usan:inn]

25. Elvitegravirum

26. 6-(3-chloro-2-fluorobenzyl)-1-((1s)-1-(hydroxymethyl)-2-methylpropyl)-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid

27. 6-[(3-chloro-2-fluoro-phenyl)methyl]-1-[(1s)-1-(hydroxymethyl)-2-methyl-propyl]-7-methoxy-4-oxo-quinoline-3-carboxylic Acid

28. Elv

29. Vitekta (tn)

30. Elvitegravir [mi]

31. Elvitegravir (jan/usan)

32. Elvitegravir [inn]

33. Elvitegravir [jan]

34. Elvitegravir (jtk-303)

35. Elvitegravir [vandf]

36. Elvitegravir [mart.]

37. Mls006011136

38. Elvitegravir [who-dd]

39. Schembl726252

40. Gtpl11574

41. Bcpp000242

42. Dtxsid101021650

43. Elvitegravir [orange Book]

44. Ex-a1542

45. Bdbm50183273

46. Mfcd11846134

47. S2001

48. Vitekta Component Elvitegravir

49. Zinc13682481

50. Elvitegravir; Gs9137; Jtk 303

51. Stribild Component Elvitegravir

52. Akos025396642

53. Bcp9000642

54. Ccg-269208

55. Compound 2 [pmid: 18281931]

56. Cs-0439

57. Db09101

58. Elvitegravir (gs-9137, Jtk-303)

59. Elvitegravir Component Of Genvoya

60. Elvitegravir Component Of Vitekta

61. Elvitegravir Component Of Stribild

62. Ncgc00346565-01

63. Ncgc00346565-04

64. Ncgc00346565-08

65. Ac-29947

66. As-16986

67. Hy-14740

68. Smr004702914

69. Elvitegravir 100 Microg/ml In Acetonitrile

70. A4070

71. Sw219721-1

72. Ec-000.2332

73. Ab01274749-01

74. Ab01274749_02

75. J-518006

76. Q2740966

77. Brd-k54472332-001-01-8

78. 3-quinolinecarboxylic Acid, 6-[(3-chloro-2-fluorophenyl)methyl]-1,4-dihydro-1-[(1s)-1-isopropyl-2-hydroxyethyl]-7-methoxy-4-oxo-

79. 6-(3-chloro-2-fluorobenzyl)-1-[(s)-1-hydroxymethyl-2-methylpropyl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid

2.4 Create Date
2005-10-07
3 Chemical and Physical Properties
Molecular Weight 447.9 g/mol
Molecular Formula C23H23ClFNO5
XLogP35.3
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count7
Rotatable Bond Count7
Exact Mass447.1248787 g/mol
Monoisotopic Mass447.1248787 g/mol
Topological Polar Surface Area87.1 Ų
Heavy Atom Count31
Formal Charge0
Complexity702
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Elvitegravir in combination with an HIV protease inhibitor coadministered with ritonavir and with other antiretroviral drug(s) is indicated for the treatment of HIV-1 infection in antiretroviral treatment-experienced adults.


FDA Label


Vitekta co-administered with a ritonavir-boosted protease inhibitor and with other antiretroviral agents, is indicated for the treatment of human-immunodeficiency-virus-1 (HIV-1) infection in adults who are infected with HIV-1 without known mutations associated with resistance to elvitegravir.


5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Anti-HIV Agents

Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. (See all compounds classified as Anti-HIV Agents.)


Anti-Retroviral Agents

Agents used to treat RETROVIRIDAE INFECTIONS. (See all compounds classified as Anti-Retroviral Agents.)


Integrase Inhibitors

Compounds which inhibit or antagonize biosynthesis or actions of integrase. (See all compounds classified as Integrase Inhibitors.)


5.2 FDA Pharmacological Classification
5.2.1 Active Moiety
ELVITEGRAVIR
5.2.2 FDA UNII
4GDQ854U53
5.2.3 Pharmacological Classes
Mechanisms of Action [MoA] - Cytochrome P450 2C9 Inducers
5.3 ATC Code

J05AX11


J - Antiinfectives for systemic use

J05 - Antivirals for systemic use

J05A - Direct acting antivirals

J05AJ - Integrase inhibitors

J05AJ02 - Elvitegravir


5.4 Absorption, Distribution and Excretion

Absorption

Following oral administration of elvitegravir and ritonavir with food, in HIV-1 infected subjects, peak elvitegravir plasma concentrations were observed approximately 4 hours post-dose.


Route of Elimination

Following oral administration of [14C]elvitegravir/ritonavir, 94.8% of the dose was recovered in feces, while 6.7% was recovered in urine as metabolites.


5.5 Metabolism/Metabolites

Elvitegravir undergoes primarily oxidative metabolism via CYP3A, and is secondarily glucuronidated via UGT1A1/3 enzymes. Metabolites are found in the plasma at very low concentrations, displayed considerably lower anti-HIV activity, and did not contribute to the overall antiviral activity of elvitegravir.


5.6 Biological Half-Life

The median terminal plasma half-life following administration of elvitegravir and ritonavir was approximately 8.7 hours.


5.7 Mechanism of Action

Elvitegravir is an HIV-1 integrase strand transfer inhibitor (INSTI). Integrase is an HIV-1 encoded enzyme that is required for viral replication. Inhibition of integrase prevents the integration of HIV-1 DNA into host genomic DNA, blocking the formation of the HIV-1 provirus and propagation of the viral infection. Elvitegravir does not inhibit human topoisomerases I or II.


API SUPPLIERS

read-more
read-more

01

Alembic Pharmaceuticals Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Duphat
Not Confirmed
arrow

Alembic Pharmaceuticals Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Duphat
Not Confirmed
USDMF arrow-down Click Us! arrow-down
CEP/COS JDMF EU-WCarrow-down NDC KDMF VMF Others AUDIT
blank

02

MSN Laboratories

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Duphat
Not Confirmed
arrow

MSN Laboratories

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Duphat
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WCInactive-api NDC arrow-down KDMF VMF Others AUDIT
blank

03

MSN Laboratories

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Duphat
Not Confirmed
arrow

MSN Laboratories

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Duphat
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

04

Shanghai Desano Chemical Pharmaceu...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Duphat
Not Confirmed
arrow

Shanghai Desano Chemical Pharmaceu...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Duphat
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

05

Gilead Sciences

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Duphat
Not Confirmed
arrow

Gilead Sciences

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Duphat
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

06

Viatris

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Duphat
Not Confirmed
arrow

Viatris

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Duphat
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

07

Viatris

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Duphat
Not Confirmed
arrow

Viatris

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Duphat
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

08

HONOUR LAB LTD

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Duphat
Not Confirmed
arrow

HONOUR LAB LTD

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Duphat
Not Confirmed
USDMF CEP/COS JDMF EU-WCInactive-api NDC arrow-down KDMF VMF Others AUDIT
blank

09

Sun-shine Chem

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Duphat
Not Confirmed
arrow

Sun-shine Chem

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Duphat
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

10

Alembic Pharmaceuticals Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Duphat
Not Confirmed
arrow

Alembic Pharmaceuticals Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Duphat
Not Confirmed
USDMF CEP/COS JDMF EU-WCInactive-api NDC KDMF VMF Others AUDIT
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

INTERMEDIATES SUPPLIERS

read-more
read-more

01

Duphat
Not Confirmed
arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothUSV offers custom peptide synthesis ranging from gram to multi-gram to multi-kilogram quantities.

CAS Number : 4276-09-9

End Use API : Elvitegravir

About The Company : USV is a leading health care company with focus on Active Pharmaceutical Ingredients (marketed globally with emphasis on regulated markets of USA, European Unio...

USV Private Limited
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - TABLET;ORAL - 150MG

USFDA APPLICATION NUMBER - 203093

read-more

DOSAGE - TABLET;ORAL - 85MG

USFDA APPLICATION NUMBER - 203093

read-more

DOSAGE - TABLET;ORAL - 150MG;150MG;200MG;300M...DOSAGE - TABLET;ORAL - 150MG;150MG;200MG;300MG

USFDA APPLICATION NUMBER - 203100

read-more

DOSAGE - TABLET;ORAL - 150MG;150MG;200MG;EQ 1...DOSAGE - TABLET;ORAL - 150MG;150MG;200MG;EQ 10MG BASE

USFDA APPLICATION NUMBER - 207561

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Coating Systems & Additives

read-more
read-more

Direct Compression

read-more
read-more

Lubricants & Glidants

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Granulation

read-more
read-more

Controlled & Modified Release

read-more
read-more

Co-Processed Excipients

read-more
read-more

Topical

read-more
read-more

Parenteral

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Taste Masking

read-more
read-more

Solubilizers

read-more
read-more

Emulsifying Agents

read-more
read-more

API Stability Enhancers

read-more
read-more

Coloring Agents

read-more
read-more

Rheology Modifiers

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Jtk 303 Manufacturers

A Jtk 303 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Jtk 303, including repackagers and relabelers. The FDA regulates Jtk 303 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Jtk 303 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Jtk 303 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Jtk 303 Suppliers

A Jtk 303 supplier is an individual or a company that provides Jtk 303 active pharmaceutical ingredient (API) or Jtk 303 finished formulations upon request. The Jtk 303 suppliers may include Jtk 303 API manufacturers, exporters, distributors and traders.

click here to find a list of Jtk 303 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Jtk 303 USDMF

A Jtk 303 DMF (Drug Master File) is a document detailing the whole manufacturing process of Jtk 303 active pharmaceutical ingredient (API) in detail. Different forms of Jtk 303 DMFs exist exist since differing nations have different regulations, such as Jtk 303 USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Jtk 303 DMF submitted to regulatory agencies in the US is known as a USDMF. Jtk 303 USDMF includes data on Jtk 303's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Jtk 303 USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Jtk 303 suppliers with USDMF on PharmaCompass.

Jtk 303 KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Jtk 303 Drug Master File in Korea (Jtk 303 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Jtk 303. The MFDS reviews the Jtk 303 KDMF as part of the drug registration process and uses the information provided in the Jtk 303 KDMF to evaluate the safety and efficacy of the drug.

After submitting a Jtk 303 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Jtk 303 API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Jtk 303 suppliers with KDMF on PharmaCompass.

Jtk 303 WC

A Jtk 303 written confirmation (Jtk 303 WC) is an official document issued by a regulatory agency to a Jtk 303 manufacturer, verifying that the manufacturing facility of a Jtk 303 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Jtk 303 APIs or Jtk 303 finished pharmaceutical products to another nation, regulatory agencies frequently require a Jtk 303 WC (written confirmation) as part of the regulatory process.

click here to find a list of Jtk 303 suppliers with Written Confirmation (WC) on PharmaCompass.

Jtk 303 NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Jtk 303 as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Jtk 303 API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Jtk 303 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Jtk 303 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Jtk 303 NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Jtk 303 suppliers with NDC on PharmaCompass.

Jtk 303 GMP

Jtk 303 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Jtk 303 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Jtk 303 GMP manufacturer or Jtk 303 GMP API supplier for your needs.

Jtk 303 CoA

A Jtk 303 CoA (Certificate of Analysis) is a formal document that attests to Jtk 303's compliance with Jtk 303 specifications and serves as a tool for batch-level quality control.

Jtk 303 CoA mostly includes findings from lab analyses of a specific batch. For each Jtk 303 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Jtk 303 may be tested according to a variety of international standards, such as European Pharmacopoeia (Jtk 303 EP), Jtk 303 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Jtk 303 USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty